Congresses and Conference Committee (C-CC)
C-CC Executive Committee (C-CC-EC)Chair:
Chair:
Prof. Tomris OZBEN (TR)
Members:
Mr. Joseph LOPEZ (MY)
Prof. James WESENBERG (CA)
Corporate Representative:
Dr. Peng YIN (US)
Corresponding Members:
Prof. Montserrat BLANES GONZALES (PY)
Prof. Pierre CARAYON (FR)
Ms. Orla Maguire (IE)
Prof. Tomas ZIMA (CZ)
7.1 Summary of C-CC
The Committee on Congresses and Conferences was established in
December 2007, and is the continuation of the former Congress and
Conference Division (CCD) which was founded in 1996, but with an
expanded charter and responsibilities. The C-CC has the major
administrative and managerial responsibility within the IFCC for
all meetings coordinated by the IFCC.
7.1.1. C-CC Mission statement
The mission of the C-CC is to provide general administration and
management of all IFCC meeting activities (congresses, conferences,
and symposia) and to review applications for IFCC auspices
from non-IFCC conferences requesting such sponsorship.
7.1.2. C-CC Strategy
The C-CC supports and promotes Clinical Laboratory Sciences
through congresses, conferences, specialised meetings, and other
professional meetings. The C-CC Works closely with the organisers
of the various IFCC related conferences to ensure that they achieve
organisational and professional excellence.
7.1.3. Projects
-
The C-CC formulates and updates as required the guidelines,
procedures and practices for IFCC-designated meetings and also
monitors compliance throughout the planning and
organizational stages. The C-CC assists the organizing groups in
the administration and promotion of conferences, and helps these
conferences obtain support, and achieve financial efficiency in the
various economical aspects of their meetings.
-
The C-CC reviews all existing meeting guidelines every three
years to ensure their continued applicability and will write new
guidelines for those meetings not covered by existing
procedures.
-
The C-CC maintains a current 5-year listing of congresses and
conferences of professional interest to the members of the IFCC,
including both IFCC related conferences and those outside the IFCC.
This allows members to be aware of these meetings and allows
potential conference organisers to plan the dates of their meetings
with care.
-
The C-CC designates as official IFCC approved meetings those
conferences that conform to the requirements of the IFCC as a
professional organisation, in order to promote the field of
clinical laboratory sciences and protect the interests of the IFCC.
Within the framework of the IFCC designated meetings, the C-CC
will promote the IFCC and its functional units and discuss
the possibility of integration of IFCC units and
members in the programme of the conference.
-
The C-CC assists in expanding the list of IFCC Master
Conferences on specific scientific and educational topics and
promotes the leadership role of the IFCC in the field of Clinical
Laboratory Sciences.
7.1.4. Members of C-CC Executive Committee and terms of
appointment
| Name |
Position |
Country |
Term |
Time in
Office |
| T. Ozben |
Chair |
TR |
2nd |
2011 01 - 2013 12 |
| J. Lopez |
Member |
MY |
1st |
2012 01 - 2014 12 |
| J. Wesemberg |
Member |
CA |
2nd |
2011 01 - 2013 12 |
| P. Yin |
Corporate Member |
US |
1st |
2012 01 - 2014 12 |
| M. Blanes Gonzales |
Corresponding Member |
PY |
1st |
2012 01 - 2014 12 |
| P. Carayon |
Corresponding Member |
FR |
2nd |
2012 01 - 2014 12 |
| O. Maguire |
Corresponding Member |
IE |
1st |
2012 01 - 2014 12 |
| T. Zima |
Corresponding Member |
CZ |
2nd |
2012 01 - 2014 12 |
7.2. International Congress of Clinical Chemistry and
Laboratory Medicine (ICCCLM)
| I |
Amsterdam (NL) |
1954 |
| II |
New York (US) |
1956 |
| III |
Stockholm (SE) |
1957 |
| IV |
Edinburgh (UK) |
1960 |
| V |
Detroit (US) |
1963 |
| VI |
Munich (DE) |
1966 |
| VII |
Geneva/Evian (CH/FR) |
1969 |
| VIII |
Copenhagen (DK) |
1972 |
| IX |
Toronto (CA) |
1975 |
| X |
Mexico City (MX) |
1978 |
| XI |
Vienna (AT) |
1981 |
| XII |
Rio de Janeiro (BR) |
1984 |
| XIII |
The Hague (NL) |
1987 |
| XIV |
San Francisco (US) |
1990 |
| XV |
Melbourne (AU) |
1993 |
| XVI |
London (UK) |
1996 |
| XVII |
Florence (IT) |
1999 |
| XVIII |
Kyoto (JP) |
2002 |
| XIX |
Orlando (US) |
2005 |
| XX |
Fortaleza (BR) |
2008 |
| XXI |
Berlin (DE) |
2011 |
| XXII |
Instanbul (TR) |
2014 |
| XXIII |
Durban (ZA) |
2017 |
7.3. IFCC Regional Congresses
7.3.1. Asian Pacific Federation of Clinical Biochemistry
(APFCB)
| III |
Singapore (SG) |
1986 |
| IV |
Hong Kong (HK) |
1988 |
| V |
Kobe (JP) |
1991 |
| VI |
Melbourne (AU) |
1993 |
| VII |
Bangkok (TH) |
1995 |
| VIII |
Kuala Lumpur (MY) |
1998 |
| IX |
New Dehli (IN) |
2001 |
| X |
Perth (AU) |
2004 |
| XI |
Beijing (CN) |
2007 |
| XII |
Seoul (KR) |
2010 |
| XIII |
Bali (ID) |
2013 |
7.3.2. European Federation of Clinical Chemistry and
Laboratory Medicine (EFCC formerly FESCC)
| I |
Munich (DE) |
1974 |
| II |
Prague (CZ) |
1976 |
| III |
Brighton (UK) |
1979 |
| IV |
Vienna (AT) |
1981 |
| V |
Budapest (HU) |
1983 |
| VI |
Jerusalem (IL) |
1985 |
| VII |
Den Hague (NL) |
1987 |
| VIII |
Milan (IT) |
1989 |
| IX |
Crakow (PL) |
1991 |
| X |
Nice (FR) |
1993 |
| XI |
Tampere (FI) |
1995 |
| XII |
Basel (CH) |
1997 |
| XIII |
Florence (IT) |
1999 |
| XIV |
Prague (CZ) |
2001 |
| XV |
Barcelona (ES) |
2003 |
| XVI |
Glasgow (UK) |
2005 |
| XVII |
Amsterdam (NL) |
2007 |
| XVIII |
Innsbruck (AT) |
2009 |
| XIX |
Berlin (DE) (with ICCCLM 2011) |
2011 |
| XX |
Milan (IT) |
2013 |
| XXI |
Paris (FR) |
2015 |
7.3.4. Latin American Confederation of Clinical Biochemistry
(COLABIOCLI)
| S.to Domingo (DO) |
1991 |
| Acapulco (MX) |
1993 |
| Buenos Aires (AR) |
1995 |
| Caracas (VE) |
1997 |
| Puerto Rico (PR) |
1999 |
| Florianopolis (BR) |
2001 |
| San José (CR) |
2003 |
| Asunciòn (PA) |
2006 |
| Panama (PAN) |
2007 |
| Santiago (CL) |
2010 |
| Punta Cana (DO) |
2011 |
| Lima (PE) |
2013 |
7.3.6. Arab Federation of Clinical Biochemistry (AFCB)
| Cairo (EG) |
1974 |
| Faihaa (SY) |
1976 |
| Cairo (EG) |
1980 |
| Cairo (EG) |
1983 |
| Cairo (EG) |
1986 |
| Tunis (TN) |
1991 |
| Faihaa (SY) |
1994 |
| Amman (JO) |
1997 |
| Rabat (MA) |
2000 |
| Monastir (TU) |
2004 |
| Damascus (SY) |
2006 |
| Beirut (LB) |
2009 |
| Marrakesh (MA) |
2012 |
| Sudan |
2015 |
7.3.7 African Federation of Clinical Chemistry (AFCC)
| Ibadan (NG) |
2009 |
| Nairobi (KE) |
2011 |
7.4. IFCC Specialized Conferences
7.4.1. IFCC-Roche Diagnostics Bergmeyer Conferences
Goals and Objectives
- The Bergmeyer Conferences founded in 1987 are a collaborative
effort of IFCC and Roche Diagnostics focused on standardisation
issues.
- The objectives of these Conferences are:
- Improving the Comparability and Compatibility of Laboratory
Assay results in life sciences;
- Improving the Clinical Value of Laboratory Data;
- Discussion of Standardisation Issues and suggesting solutions
in order to achieve the first two objectives;
- Master Discussion of Experts and a Brain Storming Forum for
projects to be executed by Scientific Division's Committees or
Working Groups.
- Each Conference is devoted to a rapid developing new area
relevant for laboratory science and clinical medicine. The scope of
a Conference is to be organised in that manner that besides
comprehensive review also future trends, analytical pitfalls and
the rationale, clinical use of the diagnostic procedures have to be
considered.
- These Conferences are Master Discussions of experts in the
respective topic of a Conference. Participation is only possible on
invitation.
- The governing body of these Conferences is the Steering
Committee consisting of IFCC (3), the editor of the proceedings (1)
and Roche Diagnostics (1) representatives.
- Conferences are held in Eibsee, Germany.
- Lectures and contributions presented at the Conferences are
published in the Conference proceedings.
Steering Committee
Name
Position
Country Time in Office
I. Young
IFCC-SD Chair
(UK)
2011 -
F. Baumann
Roche
Diagnostics
(DE)
2006 -
A. Kallner
Editor of Proceedings (SE)
1988 -
M.
Ferarri
IFCC-EMD Chair
(IT)
2012 -
T. Ozben
IFCC C-CC Chair
(TR)
2009 -
Terms of Reference
- Organisation of Bergmeyer Conferences: selection of date and
topic; responsibility for the scientific content and selection of
speakers;appointment of an ad hoc Working Group (occasionally) for
the preparation of draft documents to be circulated prior to
the respective Conference to the participants; review of the
organisational and financial commitments.
- Review of documents produced in conjunction with each
Conference;
- Submission of documents to the Scientific Division for final
approval;
- Publication of proceedings - Appointment of editors;
- The Proceedings are published in the Scandinavian Journal;
- Collaboration with Roche Diagnostics and the local organising
group
- Report to Scientific Division, information to the Congresses
and Conferences Committee;
- The Membership to be nominated by SD and approved by EB. The
terms of the IFCC members are usually 3 years; re-appointments are
possible.
Recent Conferences:
VII 1999 Biochemical markers for
myocardial damage
VIII 2001 Biochemical markers of
autoimmune disease
IX 2003 Nucleic acid markers
for bacterial and viral infections in intensive care
X 2005 Diabetes and
cardiovascular disease
XI 2008 Markers of kidney
disease
XII 2010 Novel biomarkers: from
discovery to clinical application
XIII 2012 Vitamin D in health and
disease
7.4.6. Ortho-Clinical Diagnostics
Conference
Goals and Objectives
- This Conference was inaugurated in 2008 with the generous
support of Ortho Clinical Diagnostics. It will be held every two
years starting in 2011.
- The objective of this conference is to strengthen the link
between the clinician and the clinical laboratory. Each conference
will be dedicated to a specific disease state or to particular
medical problem. The speakers will be internationally renowned
experts in the particular field that is the topic of the
conference. There will be strong participation of clinicians as
speakers. The attendance will be limited to approximately 200
persons to allow for lively discussion.
- The Scientific Division is responsible for the scientific
programme and it will appoint a chair for each conference. That
chair will take advice from expert clinicians and laboratory
medicine specialists.
- The conference proceedings will be published in the Journal,
Clinical Chemistry and Laboratory Medicine.
Conferences:
I Birmingham
(UK) 2008 Cardiac biomarkers
II Paris (FR)
2011 Pregnancy-related disorders
7.5. Congress Guidelines and Other
Documents
The following documents have been prepared by the C-CC.
- Auspices of the IFCC - Guidelines and Procedures
- Guidelines for International Congresses of Clinical Chemistry
and Laboratory Medicine (ICCCLM)
- Guidelines for EFCC European Congresses of Clinical Chemistry
and Laboratory Medicine (EuroMedLab)
7.6. IFCC General Conference
Aim
The aim of the IFCC General Conference is to convene all the
IFCC functional units at one time and location, in order to discuss
present activities and projects, and to plan and decide on future
actions of the organization.
Responsibilities
- The Committee on Congresses and Conferences (C-CC) of the IFCC
bears overall responsibility for the organization of the General
Conference.
- The IFCC Secretary is responsible for the Conference
agenda.
- The IFCC Executive Board is responsible for detailed programme
content
- The IFCC Office will carry out the administrative activities in
preparing for the Conference in collaboration with the C-CC and a
local organizing committee from the national society of the country
where the meeting is being held.
Time and Venue
- A General Conference is held once during the triennial term of
the Executive Board (EB) of IFCC, usually during the second year.
The EB decides on the time of the year at which to hold this
Conference.
- The EB will decide on the venue for the IFCC General Conference
following a recommendation from the C-CC.
- The duration of the General Conference is 2 days, and is
preceded by 2 days of an EB meeting and meetings of the Divisions
and Committees. This period is required to enable all the IFCC
functional units to meet individually and collectively.
Scope
- Prior to the General Conference all IFCC functional units carry
out their own meetings, meet with their immediate and/or Divisional
supervisors, and report on the progress of their projects and on
project proposals. The Division Executive Committees then meet with
the EB to present the status of their Division, and to obtain
consent for future and/or continuing activities.
- Representatives from Full Members and Corporate Members join
IFCC functional units for the General Conference proper.
Conferences:
I Rungestedgaard (DK)
1981
II Rungestedgaard (DK)
1984
III Monza (IT)
1988
IV Pont-a-Mousson (FR)
1992
V Leipzig (DE)
1995
VI Sevilla (ES)
1998
VII Dubrovnik (HR)
2001
VIII Sousse (TN)
2004
IX Antalya (TR)
2008
X Corfu (GR)
2010
XI Kuala Lumpur
(MY) 2012
7.7. Committee members' contact details
Prof. Tomris OZBEN
Akdeniz University Medical Faculty,
Dept. of Biochemistry
07070 Antalya, Turkey
e-mail: ozben@akdeniz.edu.tr
Mr. Joseph LOPEZ
Dept. of Biomedical Sciences
MAHSA University College
50490 Kuala Lumpur, Malaysia
e-mail: jblopez@streamyx.com
Prof. James WESENBERG
Clinical Laboratory
David Thompson Health Region
3942 50A Avenue
Red Deer, Alberta, T4N 4E7, Canada
e-mail: jwesenberg@dthr.ab.ca
Dr. Peng YIN
Global Scientific Affairs
Abbott Diagnostic Division
Abbott Bldg CP1
100 Abbott Park Road
Abbott Park, IL 60064, USA
e-mail: peng.yin@abbott.com
Corresponding Members:
Prof. Montserrat BLANES GONZALES
Grupo Habitacional Aereopuerto 248
Asuncion, Paraguay
e-mail: mblanes@ips.gov.py
Prof. Pierre CARAYON
Department of Biochemistry and Molecular Biology,
Marseille Medical School and University Hospital,
University of the Mediterranean
27 Boulevard Jean-Moulin
F-13385 Cedex 05, Marseille - France
e-mail: pierre.carayon@univmed.fr
Ms. Orla MAGUIRE
Clinical Biochemistry Department,
St Vincent's University Hospital
Elm Park
Dublin 4, Ireland
e-mail: o_maguire@hotmail.com
Prof. Tomas ZIMA
Institute of Clinical Biochemistry and Laboratory Medicine
1st Medical Faculty and General Teaching Hospital
Charles University,
U Nemocnice 2,
CZ-12108 Prague2, Czech Republic
e-mail: zimatom@cesnet.cz